Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
366 |
|
| Actual shortage: | 8 (2%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 352 (96%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (14%) |
|
Overdue reports |
3 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CEFTAZIDIME FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2020-06-25 | 2020-08-05 | 118930 |
| CEFTAZIDIME FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Resolved | 2022-04-13 | 2022-05-24 | 158756 |
| CEFTAZIDIME FOR INJECTION, USP | 6G | POWDER FOR SOLUTION | Resolved | 2022-04-13 | 2022-05-24 | 158759 |
| CEFTAZIDIME FOR INJECTION, USP | 2G | POWDER FOR SOLUTION | Resolved | 2021-12-10 | 2022-05-24 | 150950 |
| CEFTRIAXONE FOR INJECTION | 100G | POWDER FOR SOLUTION | Resolved | 2017-07-12 | 2018-05-24 | 15628 |
| CEFTRIAXONE FOR INJECTION | 100G | POWDER FOR SOLUTION | Resolved | 2018-08-10 | 2020-01-16 | 57919 |
| CEFTRIAXONE FOR INJECTION | 100G | POWDER FOR SOLUTION | Resolved | 2021-07-30 | 2021-12-30 | 143328 |
| CEFTRIAXONE FOR INJECTION | 100G | POWDER FOR SOLUTION | Resolved | 2022-04-13 | 2022-05-02 | 158762 |
| CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Resolved | 2018-06-05 | 2018-07-05 | 51491 |
| CEFUROXIME FOR INJECTION, USP | 750MG | POWDER FOR SOLUTION | Resolved | 2022-05-15 | 2022-05-31 | 160650 |
| CEFUROXIME FOR INJECTION, USP | 1.5G | POWDER FOR SOLUTION | Resolved | 2018-06-05 | 2018-07-26 | 51497 |
| CEFUROXIME FOR INJECTION, USP | 1.5G | POWDER FOR SOLUTION | Resolved | 2025-06-23 | 2025-07-11 | 260986 |
| CEFUROXIME FOR INJECTION, USP | 7.5G | POWDER FOR SOLUTION | Resolved | 2018-06-05 | 2020-01-16 | 51500 |
| CHORIONIC GONADOTROPIN FOR INJECTION, USP | 10000UNIT | POWDER FOR SOLUTION | Resolved | 2021-08-19 | 2022-02-04 | 144342 |
| CHORIONIC GONADOTROPIN FOR INJECTION, USP | 10000UNIT | POWDER FOR SOLUTION | Resolved | 2024-02-20 | 2024-03-23 | 220032 |
| CHORIONIC GONADOTROPIN FOR INJECTION, USP | 10000UNIT | POWDER FOR SOLUTION | Resolved | 2025-02-11 | 2025-03-20 | 250170 |
| CLADRIBINE INJECTION | 1MG | SOLUTION | Resolved | 2020-10-27 | 2021-01-26 | 127210 |
| CLADRIBINE INJECTION | 1MG | SOLUTION | Resolved | 2021-10-19 | 2022-02-28 | 147577 |
| CLADRIBINE INJECTION | 1MG | SOLUTION | Resolved | 2022-10-03 | 2022-12-04 | 170974 |
| CLADRIBINE INJECTION | 1MG | SOLUTION | Resolved | 2023-12-05 | 2024-04-06 | 212507 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2